EDAP TMS S.A., each representing One Ordinary Share (EDAP) News
Filter EDAP News Items
EDAP News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EDAP News Highlights
- EDAP's 30 day story count now stands at 3.
- Over the past 7 days, the trend for EDAP's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- SA and SAI are the most mentioned tickers in articles about EDAP.
Latest EDAP News From Around the Web
Below are the latest news stories about EDAP TMS SA that investors may wish to consider to help them evaluate EDAP as an investment opportunity.
Investing in EDAP TMS (NASDAQ:EDAP) five years ago would have delivered you a 155% gainIt hasn't been the best quarter for EDAP TMS S.A. ( NASDAQ:EDAP ) shareholders, since the share price has fallen 23% in... |
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate CancerRepresents Key Milestone Toward Universal Coverage for Focal One HIFU in France LYON, France, December 12, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that the French National Authority for Health (“HAS”) released a favorable recommendation for the reimbursement of high-intensity focused ultrasound (HIFU) therapy in the treatment of prostate cancer. The positive opinion from HAS is an important milestone along the regulatory p |
EDAP Appoints Lance Willsey, M.S., M.D. to Board of DirectorsLYON, France, December 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Lance Willsey, M.S., M.D. to its Board of Directors. Dr. Willsey replaces Dr. Argil Wheelock who has resigned as director of the Company. “I appreciate the opportunity to join the board of EDAP, where the company’s Focal One Robotic HIFU platform is changing the treatment paradigm in the management of prostate cancer,” sai |
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound TechnologyLYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the French National Institute for Intellectual Property (INPI) based on the Company’s innovative therapeutic ultrasound technology. On November 23, 2023, the jury for the 2023 edition of the INPI Trophies honored five companies at an awards ceremony in Paris, which spanned five different categories: Expo |
EDAP to Present at Piper Sandler’s 35th Annual Healthcare ConferenceLYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Piper Sandler 35th Annual Healthcare Conference, which is being held November 28-30, 2023, in New York, New York. Presentation details: Date:Wednesday, November 29Time:11:00 – 11:25 AM ET Location:The Lotte New York PalaceWebcast:Li |
EDAP TMS S.A.'s (NASDAQ:EDAP) top owners are individual investors with 56% stake, while 29% is held by institutionsKey Insights The considerable ownership by individual investors in EDAP TMS indicates that they collectively have a... |
EDAP TMS S.A. (NASDAQ:EDAP) Q3 2023 Earnings Call TranscriptEDAP TMS S.A. (NASDAQ:EDAP) Q3 2023 Earnings Call Transcript November 9, 2023 EDAP TMS S.A. reports earnings inline with expectations. Reported EPS is $-0.11 EPS, expectations were $-0.11. Operator: Greetings and welcome to the Edap Tms third quarter 2023 earnings conference call. At this time, all participants are in a listen only mode. A brief […] |
EDAP Announces Third Quarter 2023 Financial Results- Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year - - Record nine months HIFU revenues reflecting growing demand - - Two additional Focal One systems already placed in the fourth quarter - - Announces immunotherapy clinical research collaboration with Mount Sinai, Department of Urology - - Company to host conference call and webcast today, Thursday, November 9th at 8:30 am EDT - LYON, France, November 9, 2023 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic |
EDAP to Present at the Jefferies London Healthcare ConferenceLYON, France, November 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies London Healthcare Conference, which is being held November 14-16, 2023, in London. Presentation details: Date: Tuesday, November 14 Time: 9:00 – 9:25 AM GMT Webcast: Link The live and archived webcast of the presentation ca |
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the third quarter ended September 30th, 2023, before the markets open on Thursday, November 9th, 2023. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, François Dietsch |